Notice of Clarification to PAR-17-035 "Platform Delivery Technologies for Nucleic Acid Therapeutics (R43/R44)"

Notice Number: NOT-TR-17-020

Key Dates
Release Date: July 17, 2017

Related Announcements
PAR-17-035

Issued by
National Center for Advancing Translational Sciences (NCATS)

Purpose

The purpose of this Notice is to clarify topics of interest for PAR-17-035:  Platform Delivery Technologies for Nucleic Acid Therapeutics (R43/R44).  https://grants.nih.gov/grants/guide/pa-files/PAR-17-035.html

Section I. Funding Opportunity Description
Research Objectives

Currently reads

Applications for technologies to deliver nucleic acids into cells ex vivo (i.e. in tissue culture) or for research purposes will not be supported by this Funding Announcement

Revised to read

The focus of this Funding Announcement is on delivery technologies for nucleic acid therapeutics.   Applications for technologies to deliver nucleic acids into cells for research purposes will not be supported by this Funding Announcement.

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

PJ Brooks, Ph.D.
National Center for Advancing Translational Sciences (NCATS)
Telephone: 301-443-0513
Email: pjbrooks@mail.nih.gov